Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Zhang, Jiu Song ^a   Zhao, Qiu Min ^a   Guo, Xiao Fang ^b   Zuo, Shu Qing ^a   Cheng, Jing Xia ^c   Jia, Na ^a   Wu, Chao ^b   Dai, Pei Fang ^c   Zhao, Jun Ying ^c  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b Yunnan Institute of Parasitic Diseases   (China)

^c Shanxi Provincial Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; ASPARAGINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; LYSINE; SERINE; UNCLASSIFIED DRUG; VIRAL E PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ADOLESCENT; ADULT; AEDES ALBOPICTUS; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHINA; CLINICAL ARTICLE; COMPUTER PROGRAM; CONSENSUS SEQUENCE; CONTROLLED STUDY; FEMALE; GENETIC TRAIT; GENOTYPE; HUMAN; IMMUNOFLUORESCENCE TEST; INOCULATION; INSECT CELL; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS CAPSID; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN; GENETICS; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; VIROLOGY;

AEDES ALBOPICTUS; JAPANESE ENCEPHALITIS VIRUS;

AGED, 80 AND OVER; AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; CHINA; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; GENOTYPE; HUMANS; MALE; PHYLOGENY; VACCINES, ATTENUATED; VIRAL PROTEINS;

EID: 79551507900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016418     Document Type: Article

References (27)

1. Solomon T (2006) Control of Japanese encephalitis-within our grasp? N Engl J Med 355: 869-871.
2. Ghosh D, Basu A (2009) Japanese encephalitis-a pathological and clinical perspective. PLoS Negl Trop Dis 3: 1-7.
3. Liang GD (2005) Research in arbovirus should be strengthened in China. Chin J Exp Clin Virol 19: 305-306.
4. Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K (2009) Past, present, and future of Japanese encephalitis. Emerg Infect Dis 15: 1-7.
5. Solomon T (2004) Flavivirus encephalitis. N Engl J Med 351: 370-378.
6. Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, et al. (1987) Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161: 497-510.
7. Chen WR, Tesh RB, Rico-Hesse R (1990) Genetic variation of Japanese encephalitis virus in nature. J Gen Virol 71: 2915-2922.
8. Chen WR, Rico-Hesse R, Tesh RB (1992) A new genotype of Japanese encephalitis virus from Indonesia. Am J Trop Med Hyg 47: 61-69.
9. Wang HY, Takasaki T, Fu SH, Sun XH, Zhang HL, et al. (2007) Molecular epidemiological analysis of Japanese encephalitis virus in China. J Gen Virol 88: 885-894.
10. Wang LH, Fu SH, Wang HY, Liang XF, Cheng JX, et al. (2007) Japanese encephalitis outbreak, Yuncheng, China, 2006. Emerg Infect Dis 13: 1123-1125.
11. Kuwayama M, Ito M, Takao S, Shimazu Y, Fukuda S, et al. (2005) Japanese encephalitis virus in meningitis patients, Japan. Emerg Infect Dis 11: 471-473.
12. Ye X, Wang H, Fu S, Gao X, Zhao S, et al. (2010) Etiological spectrum of clinically diagnosed Japanese encephalitis cases reported in Guizhou Province, China, in 2006. J Clin Microb 48: 1343-1349.
13. Wang XJ, Zhang YP, Zhang RZ (2004) Analysis on epidemic trend of Japanese B encephalitis during 1998-2002. Chin J Vaccines Immun 10: 215-217.
14. Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
15. Ronquist F, Huelsenbeck JP (2003) MRBAYES 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19: 1572-1574.
16. Zhang JS, Zhao QM, Zhang PH, Jia N, Cao WC (2009) Genomic sequence of a Japanese encephalitis virus isolate from southern China. Arch Virol 154: 1177-1180.
17. Wang HY, Gao XY, Song LZ, Li Y, Liu GF, et al. (2009) Isolation and identification of Japanese encephalitis virus firstly in Shandong Province. Chin J Vaccines Immun 15: 337-340.
18. Liu W, Clemens JD, Yang J, Xu ZY (2006) Immunization against Japanese encephalitis in China: A policy analysis. Vaccine 24: 5178-5182.
19. Westaway EG (1987) Flavivirus replication strategy. Adv Virus Res 33: 45-90.
20. Ni H, Chang GJJ, Xie H, Trent DW, Barrett ADT (1995) Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14. J Gen Virol 76: 409-413.
21. Tajima S, Nerome R, Nukui Y, Kato F, Takasaki T, et al. (2010) A single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice. Virology 396: 298-304.
22. Mason PW, Dalrymple JM, Gentry MK, McCown JM, Hoke CH, et al. (1989) Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol 70: 2037-2049.
23. Lin CW, Wu SC (2003) A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizingantibody combining sites. J Virol 77: 2600-2606.
24. Takada K, Masaki H, Konishi E, Takahashi M, Kurane I (2000) Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8 + cytotoxic T lymphocytes. Arch Virol 145: 523-534.
25. Lin YL, Chen LK, Liao CL, Yeh CT, Ma SH, et al. (1998) DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol 72: 191-200.
26. Xu G, Xu X, Li Z, He Q, Wu B, et al. (2004) Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. Vaccine 22: 1846-1853.
27. Lin CW, Liu KT, Huang HD, Chen WJ (2008) Protective immunity of E. colisynthesized NS1 protein of Japanese encephalitis virus. Biotechnol Lett 30: 205-214.